- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07861971
Feasibility Study of a Sports-Inspired Onco-Coaching Progranm for Young Adults i Cancer Remission (rebond-jas)
REBOND JAS: Feasibility Study of a Sport-Inspired Onco-Coaching Program for Young Adults in Cancer Remission: Rebond-JAs-IPC 2025-017
This is a single-center, non-randomized feasibility study. For this study, 19 young adults treated for cancer at the Paoli-Calmettes Institute will be included.This study includes interviews and questionnaires to assess the adherence rate. It will be measured by the percentage of patients who attend the first two coaching sessions (either in person or via videoconference) relative to the total number of patients included in the study.
The invitation to participate in this program will be made by the surgeon, hematologist, oncologist, or radiation therapist.
Studieoversikt
Status
Forhold
Detaljert beskrivelse
The first coaching session must take place within one month following inclusion. Coaching sessions will involve all patients enrolled in the study.
Coaching sessions with the coach will be offered as monthly individual interviews over a period ranging from 2 to 6 months. The frequency of sessions will be co-determined by the coach and the participant, depending on the participant's needs. The coach will aim to schedule sessions with at least one month between them. Therefore, patients will have a minimum of 2 and a maximum of 6 onco-coaching sessions.
Sessions will be held at the Faculty of Sports Sciences, in a dedicated office. The first session must be conducted in person. Subsequent sessions may be conducted remotely (by phone or videoconference), depending on patient preferences. This option is supported by findings from recent studies (McCann et al., 2019; Mostafa et al., 2025; Zhong et al., 2025).
During sessions, the coach uses standard motivational interviewing techniques (Miller, 1983). Through the use of open-ended questions, active and reflective listening, positive reinforcement and validation techniques, as well as regular reformulation of what is expressed, the coach reveals contradictions and ambivalence, defuses resistance, and promotes self-determined strategies for change (Miller and Rollnick, 2002).
From the first session, the coach works with each participant to define personalized goals and a strategy to achieve them, including identifying available resources. Each session should last between 45 minutes and 1 hour.Questionnaires:
QEEC-AYAs: A tool designed to measure the psychosocial needs of adolescents and young adults during and after treatment. Developed by Justafré et al. (2023), it includes 48 items divided into 7 dimensions: information (8 items), care team (6 items), physical health (4 items), emotional health (14 items), sexual and reproductive health (6 items), health behaviors and well-being (4 items), and daily life (6 items). The questionnaire demonstrates strong psychometric properties, with Cronbach's alpha values above 0.80.
Interviews:
These semi-structured interviews will be conducted to analyze the impact of the intervention on patients and to better understand the underlying processes. They will be carried out by researchers specialized in social psychology and quantitative data analysis, using a semi-structured adaptive interview guide. Each interview will last between 30 minutes and 1 hour.
The first semi-structured interview will be conducted in a room at the Faculty of Sports Sciences by at least two researchers. The second interview may be conducted either remotely or in person at the Faculty of Sports Sciences.
All interviews must be recorded using a voice recorder, then pseudonymized (only the study ID number) and transferred to the secure server of the Management Sport Cancer laboratory. The recordings must then be deleted from the voice recorder.
Studietype
Registrering (Antatt)
Kontakter og plasseringer
Studiekontakt
- Navn: jihane pakradouni, PhD
- Telefonnummer: +33491223778
- E-post: DRCI.UP@ipc.unicancer.fr
Studiesteder
-
-
-
Marseille, Frankrike, 13009
- Rekruttering
- Institut Paoli-Calmettes
-
Ta kontakt med:
- Marie-anne Hospital, MD
- Telefonnummer: 0491227742
- E-post: HOSPITALM@ipc.unicancer.fr
-
Ta kontakt med:
- Allison Arthur
- Telefonnummer: 0491223448
- E-post: arthura@ipc.unicancer.fr
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Male or female aged 18 to 25 at the time of cancer diagnosis and/or at the time of inclusion.In complete remission, within one year following the end of treatment and at the time of inclusion
Beskrivelse
Inclusion Criteria:
- Male or female aged 18 to 25 at the time of cancer diagnosis and/or at the time of inclusion.
- In complete remission, within one year following the end of treatment and at the time of inclusion.
- Treated at the Comprehensive Cancer Center Institut Paoli-Calmettes.
- Able to speak and write in French.
- Has not objected to participation in the study.
- Affiliated with a social security scheme or beneficiary of such a scheme.
Non -Inclusion Criteria:
- Patient undergoing treatment, except for maintenance therapy.
- Patient experiencing a relapse.
- Person in an emergency situation, legally protected adult (under guardianship, curatorship, or judicial protection), or unable to express non-opposition.
- Patient with clinically confirmed psychological symptoms (e.g., receiving antidepressants, mood stabilizers, anxiolytics, etc.).
- Inability to comply with study follow-up due to geographic, social, or psychological reasons.
Exclusion Criteria:
Relapse occurring between inclusion and the second onco-coaching session.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: OTHER
- Tidsperspektiver: PROSPECTIVE
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
The primary objective of the study is to assess the feasibility of a sport-inspired onco-coaching program by evaluating the participation rate of young adults in the first two coaching sessions.
Tidsramme: 2 years
|
The primary evaluation criterion of the study will be the adherence rate to the onco-coaching program. It will be measured by the percentage of patients who attend the first two coaching sessions (either in person or via videoconference) relative to the total number of patients enrolled in the study. The invitation to participate in the program will be made by the surgeon, hematologist, oncologist, or radiation therapist. |
2 years
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
To identify the success and failure factors of the extrahospital support program through qualitative interviews.
Tidsramme: 2 years
|
Assessment of participants' satisfaction with the program through semi-structured interviews |
2 years
|
|
To evaluate overall adherence to the onco-coaching program
Tidsramme: 2 years
|
Compliance with the onco-coaching program, measured empirically across all scheduled visits by assigning equal weight to all participants, regardless of the number of visits planned. |
2 years
|
|
To collect and characterize the reasons why patients decline to participate in the study
Tidsramme: 2 years
|
Number of refusals to sign the informed consent form. |
2 years
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- Rebond-JAs-IPC 2025-017
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .